Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Soligenix's SGX-943 gets FDA fast track designation

June 1, 2016

EMA committee recommends approval of Epclusa for hepatitis C

May 30, 2016

FORGE Life Science develops antivirals

May 30, 2016

Merck & Co. receives positive opinion for Zepatier in the E.U.

May 30, 2016

Australian institutions sign MOU to establish Australian Hepatitis C Elimination Program

May 30, 2016

FDA grants new QIDP designation to MBN-101

May 27, 2016

Quretech introduces antibacterial compounds

May 27, 2016

Symbiomix reports clinical results for SYM-1219

May 27, 2016

Spero Therapeutics signs research agreement with Vertex Pharmaceuticals

May 27, 2016

FDA grants orphan drug designation to Viamet's VT-1598

May 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...